BLUE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,849.60

bluebird bio Insider Trading History Chart

bluebird bio Share Price & Price History

^$8.50

▼ -0.73 (-7.91%)

As of 12/20/2024 06:45 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

bluebird bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/10/2024	Andrew Obenshain	CEO	Sell	48	$8.40	$403.20	18,712
2/5/2024	Andrew Obenshain	CEO	Sell	93	$18.00	$1,674.00	14,304
2/5/2024	Thomas J Klima	Insider	Sell	135	$18.00	$2,430.00	6,470
1/5/2024	Andrew Obenshain	CEO	Sell	158	$28.60	$4,518.80	14,398
1/5/2024	Richard A Colvin	Insider	Sell	29	$28.40	$823.60	6,256
12/6/2023	Christopher Krawtschuk	CFO	Sell	226	$90.40	$20,430.40	2,273
9/5/2023	Thomas J Klima	Insider	Sell	46	$75.80	$3,486.80	6,606
8/10/2023	Andrew Obenshain	CEO	Sell	846	$70.80	$59,896.80	14,597
6/2/2023	Thomas J Klima	Insider	Sell	206	$70.00	$14,420.00	6,652
1/11/2023	Andrew Obenshain	CEO	Sell	158	$156.00	$24,648.00	12,134
1/11/2023	Nick Leschly	Director	Sell	214	$156.00	$33,384.00	14,007
1/11/2023	Richard A Colvin	Insider	Sell	27	$156.00	$4,212.00	3,711
11/4/2022	Andrew Obenshain	CEO	Sell	63	$128.20	$8,076.60	12,293
11/4/2022	Richard A Colvin	Insider	Sell	10	$128.20	$1,282.00	3,739
8/19/2022	Jason Cole	Insider	Sell	709	$110.60	$78,415.40	9,477
8/4/2022	Andrew Obenshain	CEO	Sell	1,090	$87.80	$95,702.00	12,356
8/4/2022	Jason Cole	Insider	Sell	372	$87.80	$32,661.60	10,187
7/12/2022	Anne-Virginie Eggimann	Insider	Sell	67	$99.00	$6,633.00	2,112
6/3/2022	Thomas J Klima	Insider	Sell	187	$61.40	$11,481.80	3,571
1/10/2022	Andrew Obenshain	CEO	Sell	152	$187.20	$28,454.40
1/10/2022	Jason Cole	Insider	Sell	79	$188.00	$14,852.00
1/10/2022	Jessica Whitten	CAO	Sell	6	$188.00	$1,128.00
1/10/2022	Nick Leschly	Director	Sell	118	$188.00	$22,184.00
1/5/2022	Jessica Whitten	CAO	Sell	149	$208.80	$31,111.20

The #1 Coin for November 2024

From Crypto 101 Media | Ad

Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

SEC Filings (Institutional Ownership Changes) for bluebird bio (NASDAQ:BLUE)

87.43% of bluebird bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

bluebird bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	252,062	$0.13M	0.0%	+273.7%	0.130%
11/16/2024	Geode Capital Management LLC	4,683,042	$2.43M	0.0%	+3.7%	2.415%
11/15/2024	Barclays PLC	252,062	$0.13M	0.0%	+273.7%	0.130%
11/15/2024	Jane Street Group LLC	259,219	$0.14M	0.0%	-76.6%	0.134%
11/15/2024	State Street Corp	3,841,923	$2M	0.0%	+1.1%	1.981%
11/14/2024	Verition Fund Management LLC	81,127	$42K	0.0%	N/A	0.042%
11/14/2024	Captrust Financial Advisors	237,648	$0.12M	0.0%	+48.2%	0.123%
11/13/2024	BNP Paribas Financial Markets	371,224	$0.19M	0.0%	+2,270.2%	0.191%
11/13/2024	FMR LLC	2,481,965	$1.29M	0.0%	+8.1%	1.280%
10/3/2024	SG Americas Securities LLC	122,855	$64K	0.0%	+152.4%	0.112%
8/15/2024	Lion Point Capital LP	678,256	$0.67M	1.2%	-20.0%	0.620%
8/15/2024	The Manufacturers Life Insurance Company	29,811	$29K	0.0%	-50.6%	0.027%
8/15/2024	Millennium Management LLC	5,146,653	$5.07M	0.0%	-17.5%	4.707%
8/15/2024	AQR Capital Management LLC	1,334,519	$1.22M	0.0%	+315.3%	1.221%
8/14/2024	Masters Capital Management LLC	975,000	$0.96M	0.1%	-2.5%	0.892%
8/14/2024	ProShare Advisors LLC	37,399	$37K	0.0%	-21.7%	0.034%
8/9/2024	Renaissance Technologies LLC	791,504	$0.78M	0.0%	-63.8%	0.724%
8/9/2024	Dimensional Fund Advisors LP	748,299	$0.74M	0.0%	-54.6%	0.684%
8/2/2024	Allegheny Financial Group LTD	25,000	$25K	0.0%	N/A	0.023%
8/1/2024	Rhumbline Advisers	292,436	$0.29M	0.0%	+25.4%	0.267%
7/29/2024	Principal Financial Group Inc.	28,583	$28K	0.0%	-26.8%	0.026%
7/26/2024	Bank of New York Mellon Corp	685,757	$0.68M	0.0%	+19.4%	0.627%
7/12/2024	SG Americas Securities LLC	48,670	$48K	0.0%	-39.2%	0.045%
5/16/2024	Bayesian Capital Management LP	40,443	$52K	0.0%	N/A	0.037%
5/15/2024	Price T Rowe Associates Inc. MD	54,714	$71K	0.0%	+113.7%	0.050%
5/14/2024	American International Group Inc.	94,371	$0.12M	0.0%	+77.4%	0.086%
5/10/2024	Vanguard Group Inc.	10,498,460	$13.44M	0.0%	+19.6%	9.602%
5/7/2024	SG Americas Securities LLC	80,032	$0.10M	0.0%	+458.8%	0.073%
5/1/2024	BNP Paribas Financial Markets	102,100	$0.13M	0.0%	-80.6%	0.093%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	325,111	$0.42M	0.0%	+38.4%	0.297%
5/1/2024	Sequoia Financial Advisors LLC	40,085	$51K	0.0%	+48.0%	0.037%
4/29/2024	China Universal Asset Management Co. Ltd.	36,580	$47K	0.0%	+189.2%	0.033%
4/10/2024	Enterprise Bank & Trust Co	30,000	$38K	0.0%	N/A	0.027%
3/14/2024	HBK Investments L P	1,500,000	$2.07M	0.0%	N/A	1.372%
2/26/2024	Virtu Financial LLC	229,542	$0.32M	0.0%	N/A	0.210%
2/15/2024	PFM Health Sciences LP	2,042,651	$2.82M	0.2%	-66.2%	1.868%
2/15/2024	Birchview Capital LP	321,200	$0.44M	0.4%	-29.4%	0.294%
2/14/2024	Masters Capital Management LLC	1,000,000	$1.38M	0.1%	N/A	0.915%
2/14/2024	Pennant Investors LP	87,400	$0.12M	0.0%	N/A	0.080%
2/14/2024	Ghisallo Capital Management LLC	3,150,000	$4.35M	0.4%	N/A	2.881%
2/14/2024	Vestal Point Capital LP	2,150,000	$2.97M	0.3%	N/A	1.966%
2/13/2024	Tower Research Capital LLC TRC	44,844	$62K	0.0%	+108.9%	0.041%
2/13/2024	Rafferty Asset Management LLC	1,425,873	$1.97M	0.0%	-4.4%	1.304%
2/12/2024	Monashee Investment Management LLC	500,000	$0.69M	0.1%	N/A	0.457%
2/12/2024	Weiss Asset Management LP	750,000	$1.04M	0.1%	N/A	0.686%
2/12/2024	Contrarius Investment Management Ltd	1,206,506	$1.67M	0.1%	-7.8%	1.103%
2/9/2024	Dynamic Technology Lab Private Ltd	26,760	$37K	0.0%	N/A	0.024%
2/8/2024	Summit X LLC	178,952	$0.25M	0.1%	+10.2%	0.164%
2/8/2024	Panagora Asset Management Inc.	113,362	$0.16M	0.0%	-67.9%	0.104%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	64,167	$88K	0.0%	-17.7%	0.059%
2/7/2024	Johnson Investment Counsel Inc.	27,889	$38K	0.0%	+111.1%	0.026%
2/7/2024	BNP Paribas Financial Markets	524,963	$0.72M	0.0%	+144.7%	0.480%
2/7/2024	Monaco Asset Management SAM	150,000	$0.21M	0.1%	N/A	0.137%
2/5/2024	Russell Investments Group Ltd.	84,601	$0.12M	0.0%	-14.2%	0.077%
2/1/2024	New York State Common Retirement Fund	190,685	$0.26M	0.0%	+67.0%	0.174%
1/26/2024	Cerity Partners LLC	59,623	$82K	0.0%	N/A	0.055%
1/26/2024	Sequoia Financial Advisors LLC	27,085	$37K	0.0%	N/A	0.025%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	234,972	$0.32M	0.0%	-58.8%	0.215%
12/18/2023	Vanguard Group Inc.	5,617,460	$17.08M	0.0%	+0.8%	5.138%
12/7/2023	Hudson Bay Capital Management LP	327,500	$1M	0.0%	+9.2%	0.300%
12/1/2023	Wellington Management Group LLP	582,168	$1.77M	0.0%	+4.8%	0.532%
11/17/2023	Jacobs Levy Equity Management Inc.	1,841,584	$5.60M	0.0%	-11.9%	1.684%
11/14/2023	Caxton Associates LP	152,389	$0.46M	0.1%	+187.9%	0.139%
11/14/2023	Profund Advisors LLC	216,366	$0.66M	0.0%	-26.6%	0.198%
11/13/2023	Aigen Investment Management LP	11,305	$34K	0.0%	N/A	0.010%
11/13/2023	Rafferty Asset Management LLC	1,491,411	$4.53M	0.0%	-18.8%	1.364%
11/13/2023	Johnson Investment Counsel Inc.	13,209	$40K	0.0%	N/A	0.012%
11/13/2023	E Fund Management Co. Ltd.	66,978	$0.20M	0.0%	-24.4%	0.061%
11/9/2023	Bleichroeder LP	900,000	$2.74M	0.7%	N/A	0.842%
11/9/2023	Deutsche Bank AG	692,881	$2.11M	0.0%	+80.8%	0.648%
11/9/2023	Citigroup Inc.	557,969	$1.70M	0.0%	+5.8%	0.522%
11/7/2023	Virtus ETF Advisers LLC	78,827	$0.24M	0.1%	-11.5%	0.074%
11/7/2023	New York State Common Retirement Fund	114,195	$0.35M	0.0%	+17.0%	0.107%
11/7/2023	Barclays PLC	627,815	$1.91M	0.0%	-16.4%	0.587%
11/7/2023	Jump Financial LLC	21,261	$65K	0.0%	-90.4%	0.020%
11/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	77,996	$0.24M	0.0%	+6.5%	0.073%
11/6/2023	Summit X LLC	162,368	$0.49M	0.2%	-27.0%	0.152%
10/27/2023	Hennion & Walsh Asset Management Inc.	48,666	$0.15M	0.0%	-16.5%	0.046%
10/27/2023	Allspring Global Investments Holdings LLC	22,332	$68K	0.0%	-41.1%	0.021%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	570,932	$1.74M	0.0%	+5.6%	0.534%
10/24/2023	Bank of New York Mellon Corp	411,466	$1.25M	0.0%	+1.5%	0.385%
9/21/2023	Barclays PLC	750,753	$2.47M	0.0%	+34.8%	0.702%
8/14/2023	Granahan Investment Management LLC	4,856,322	$15.98M	0.5%	+236.0%	4.541%
8/14/2023	Graham Capital Management L.P.	95,052	$0.31M	0.0%	N/A	0.089%
8/11/2023	Panagora Asset Management Inc.	352,603	$1.16M	0.0%	+9.4%	0.330%
8/11/2023	Quinn Opportunity Partners LLC	26,624	$88K	0.0%	-39.7%	0.025%
8/11/2023	E Fund Management Co. Ltd.	88,590	$0.29M	0.0%	-3.9%	0.083%
8/11/2023	ExodusPoint Capital Management LP	271,627	$0.89M	0.0%	N/A	0.255%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	540,471	$1.77M	0.0%	+40.0%	0.508%
8/10/2023	Summit X LLC	222,445	$0.73M	0.2%	+16.0%	0.209%
8/9/2023	BNP Paribas Arbitrage SNC	330,297	$1.09M	0.0%	-46.1%	0.310%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	73,245	$0.24M	0.0%	+93.2%	0.069%
8/7/2023	Principal Financial Group Inc.	38,391	$0.13M	0.0%	+22.4%	0.036%
8/7/2023	TrinityPoint Wealth LLC	10,000	$33K	0.0%	-50.0%	0.009%
8/3/2023	Barclays PLC	750,753	$2.47M	0.0%	+34.8%	0.706%
7/31/2023	Brighton Jones LLC	24,710	$81K	0.0%	-10.3%	0.023%
7/31/2023	Daiwa Securities Group Inc.	23,084	$76K	0.0%	+146.7%	0.022%
7/31/2023	Sargent Investment Group LLC	24,324	$80K	0.0%	N/A	0.023%
7/26/2023	Channel Wealth LLC	12,500	$41K	0.0%	N/A	0.012%
7/24/2023	Allspring Global Investments Holdings LLC	37,905	$0.13M	0.0%	+606.5%	0.036%

Data available starting January 2016

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Today's Range

Now: $8.50

$7.94

$9.80

50 Day Range

MA: $8.53

$5.89

$14.73

52 Week Range

Now: $8.50

$5.80

$38.40

Volume

899,239 shs

Average Volume

398,183 shs

Market Capitalization

$82.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of bluebird bio?: bluebird bio's top insider shareholders include:
Andrew Obenshain (CEO)
Nick Leschly (Director)
Thomas J Klima (Insider)
Richard A Colvin (Insider)
Christopher Krawtschuk (CFO)
Learn More about top insider investors at bluebird bio.
Who are the major institutional investors of bluebird bio?: bluebird bio's top institutional investors include:
Geode Capital Management LLC — 2.42%
State Street Corp — 1.98%
FMR LLC — 1.28%
BNP Paribas Financial Markets — 0.19%
Jane Street Group LLC — 0.13%
Barclays PLC — 0.13%
Learn More about top institutional investors of bluebird bio stock.
Which institutional investors are selling bluebird bio stock?: In the previous quarter, BLUE stock was sold by these institutional investors:
Jane Street Group LLC
In the last year, company insiders that have sold bluebird bio company stock include:
Andrew Obenshain (CEO)
Nick Leschly (Director)
Thomas J Klima (Insider)
Learn More investors selling bluebird bio stock.
Which institutional investors are buying bluebird bio stock?: During the previous quarter, BLUE stock was purchased by institutional investors including:
BNP Paribas Financial Markets
FMR LLC
Barclays PLC
Barclays PLC
Geode Capital Management LLC
Verition Fund Management LLC
Captrust Financial Advisors
SG Americas Securities LLC